Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lahm

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Proteins|June 22, 2000
A model for the hepatitis C virus envelope glycoprotein E2A T Yagnik, A Lahm, A Meola, et al.
Archives of Orthopaedic and Trauma Surgery|January 31, 2014
An economic analysis of aseptic revision hip arthroplasty: calculation of partial hospital costs in relation to reimbursementG Assmann, R Kasch, A Hofer, et al.
The EMBO Journal|December 15, 1994
Rational design of a receptor super-antagonist of human interleukin-6R Savino, L Ciapponi, A Lahm, et al.
The Journal of Biological Chemistry|June 5, 1998
Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processingE Candi, G Melino, A Lahm, et al.
International Journal of Sports Medicine|December 1, 2007
Tibial wedge osteotomy for osteochondral transplantation in talar lesionsP C Kreuz, A Lahm, M Haag, et al.
The EMBO Journal|March 15, 1994
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationR Savino, A Lahm, A L Salvati, et al.
The EMBO Journal|June 3, 1996
Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivityC Toniatti, A Cabibbo, E Sporena, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 23, 2006
Impacts of roads and hunting on central African rainforest mammalsWilliam E Laurance, Barbara M Croes, Landry Tchignoumba, et al.
The EMBO Journal|May 1, 1995
Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signallingG Paonessa, R Graziani, A De Serio, et al.
Journal of Virology|September 18, 2001
Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor proteinM Pallaoro, A Lahm, G Biasiol, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Proteins|June 22, 2000
A model for the hepatitis C virus envelope glycoprotein E2A T Yagnik, A Lahm, A Meola, et al.
Archives of Orthopaedic and Trauma Surgery|January 31, 2014
An economic analysis of aseptic revision hip arthroplasty: calculation of partial hospital costs in relation to reimbursementG Assmann, R Kasch, A Hofer, et al.
The EMBO Journal|December 15, 1994
Rational design of a receptor super-antagonist of human interleukin-6R Savino, L Ciapponi, A Lahm, et al.
The Journal of Biological Chemistry|June 5, 1998
Transglutaminase 1 mutations in lamellar ichthyosis. Loss of activity due to failure of activation by proteolytic processingE Candi, G Melino, A Lahm, et al.
International Journal of Sports Medicine|December 1, 2007
Tibial wedge osteotomy for osteochondral transplantation in talar lesionsP C Kreuz, A Lahm, M Haag, et al.
The EMBO Journal|March 15, 1994
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activationR Savino, A Lahm, A L Salvati, et al.
The EMBO Journal|June 3, 1996
Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivityC Toniatti, A Cabibbo, E Sporena, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 23, 2006
Impacts of roads and hunting on central African rainforest mammalsWilliam E Laurance, Barbara M Croes, Landry Tchignoumba, et al.
The EMBO Journal|May 1, 1995
Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signallingG Paonessa, R Graziani, A De Serio, et al.
Journal of Virology|September 18, 2001
Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor proteinM Pallaoro, A Lahm, G Biasiol, et al.
Pageof 8